Reaction
Steatohepatitis reporting signals
As of the last recalculation, Steatohepatitis appears in 531 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is PEGASPARGASE (PRR 35.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pegaspargase | 11 | 35.9 | 36.0 |
| Oxaliplatin | 45 | 25.9 | 25.9 |
| Canakinumab | 7 | 25.7 | 25.7 |
| Fluorouracil Cream, 0.5% | 43 | 24.0 | 24.0 |
| Fluorouracil | 43 | 23.6 | 23.6 |
| Tofacitinib Citrate | 7 | 21.2 | 21.2 |
| Irinotecan Hydrochloride | 6 | 18.5 | 18.5 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate | 3 | 13.1 | 13.1 |